The medication acts by stimulating GLP-1 receptors that influence appetite regulation and energy balance
Understanding your unique peptide pathways through precision testing helps determine whether combining these approaches aligns with your metabolic profile
Oncology 33(3):110113
2 Search strategy and selection criteria We searched online databases, including PubMed, ISI Web of Science and Scopus, for publications with the following MeSH terms: glucagon-like peptide-1 receptor agonists (GLP-1RA), dipeptidyl-peptidase 4 inhibitors (DPP-4i), sodium-glucose co-transporter 2 inhibitors (SGLT-2i),GLP-1R and glucose-dependent insulinotropic polypeptide (GIP) receptor dual agonists , semagutide, Tirzepatide , Diabetes Mellitus, anti-diabetic drugs, each of these terms in combination with neuroendocrine tumors (NET), pancreatic neuroendocrine tumors, gastro-entero pancreatic neuroendocrine tumors, lung neuroendocrine tumors, bronchial neuroendocrine tumors, pheocromocitoma/paraganglioma, and cancer
